Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
about
Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down SyndromeHedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse modelA 'cure' for Down syndrome: what do parents want?Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.Disinhibition, an emerging pharmacology of learning and memoryAging and intellectual disability: insights from mouse models of Down syndrome.Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.
P2860
Q27324486-E87C2F92-D7D8-431B-8C9B-C2DF444FB4A5Q33552991-EAE2B36B-7D14-4416-A005-4F5FE54FDAD9Q33747513-5C72DC3A-3E17-4044-B842-FB2493E68E17Q36522425-380622C4-5024-4EE6-933C-A13762F883ADQ37635772-58E3B428-0BD3-4E81-8B53-D9410D62731DQ38129324-6AA439DD-2E18-48D7-A68E-4E030735934EQ47289623-59FB422C-917F-482A-85B1-D5469E5B564F
P2860
Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
@en
type
label
Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
@en
prefLabel
Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
@en
P2860
P1476
Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome
@en
P2093
Matthew L Pearn
William C Mobley
P2860
P304
P356
10.1016/J.CONB.2012.05.002
P577
2012-05-30T00:00:00Z